stockrowHims & Hers Health, Inc.
HIMS Healthcare Drug Manufacturers Specialty & Generic
Hims & Hers Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.3 billion, up 59.0% from fiscal 2024.
- Revenue
- +38.3%
- EPS
- −294.7%
- Free cash flow
- +5.09%
- Total debt
- +40.8%
Quarter to June 2026, against a year earlier
Follow HIMS
Alert me
Hims & Hers Health, Inc. (HIMS) Free cash flow
Hims & Hers Health, Inc.'s free cash flow for fiscal 2025 was $74.0M, down 64.7% from $209.4M in fiscal 2024. Over the twelve months to 30 June 2026 it was $83.0M. Over the past ten years it has ranged from −$75.2M (fiscal 2019) to $209.4M (fiscal 2024); the current reading is higher than 91% of that period. Hims & Hers Health, Inc. ranks 24th of 84 Drug Manufacturers Specialty & Generic companies by free cash flow.
Free cash flow, annual
Embed this chart
Annual newest first
| Period | Free cash flow | Change |
|---|---|---|
| FY2025 | $74.0M | (64.68%) |
| FY2024 | $209.4M | 272.23% |
| FY2023 | $56.3M | — |
| FY2022 | −$29.2M | — |
| FY2022 | −$26.5M | — |
| FY2021 | −$35.2M | — |
| FY2021 | −$34.4M | — |
| FY2020 | −$4.2M | — |
| FY2020 | −$2.5M | — |
| FY2019 | −$75.2M | — |
Quarterly newest first
| Period | Free cash flow | Change |
|---|---|---|
| Jun 2026 | −$61.9M | — |
| Mar 2026 | $59.5M | 2,993.14% |
| Dec 2025 | $1.9M | (97.69%) |
| Sep 2025 | $83.5M | — |
| 25 more quarters | Free account |
Against its own ten years
Free cash flow against peers
| Company | Free cash flow |
|---|---|
| LNTH Lantheus Holdings, Inc. compare | $409.5M |
| ALKS Alkermes plc compare | $228.4M |
| KNSA Kiniksa Pharmaceuticals International, plc compare | $197.2M |
| LQDA Liquidia Corporation compare | $150.7M |
| RDY Dr. Reddy's Laboratories Ltd compare | $96.0M |
| HIMS Hims & Hers Health, Inc. | $83.0M |
| SUPN Indivior Pharmaceuticals Inc. compare | $31.0M |
| AMRX AMNEAL PHARMACEUTICALS, INC. compare | −$60.5M |
| AMLX Amylyx Pharmaceuticals, Inc. compare | −$130.7M |
What Free cash flow is
Free Cash Flow tells an investor how much cash a company’s operations generate after paying for its investment in physical and intangible assets.
Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)
More on HIMS
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- The full statement